P258 - Benefit of Gonadotropin-releasing Hormone (GnRH) agonist administration with Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2-Negative subtype for young breast cancer patients

Saved in:
Bibliographic Details
Published inBreast (Edinburgh) Vol. 32; p. S108
Main Authors Yoon, T.I., Lee, S.B., Sohn, G., Ko, B.S., Lee, J.W., Son, B.H., Ahn, S.H., Kim, H.J.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.03.2017
Online AccessGet full text

Cover

More Information
ISSN:0960-9776
1532-3080
DOI:10.1016/S0960-9776(17)30344-2